Bangrui Biotech-Create Announces Ex-Rights Date and Related Matters

1. Date of Board, Shareholders' Meeting Resolution or Company Decision: 115/08/10 2. Type of Rights Adjustment (please enter 'Ex-Rights', 'Ex-Dividend', or 'Ex-Rights and Ex-Dividend'): Ex-Rights 3. Ordinary Share Dividend Type and Amount: (1) Capitalization of retained earnings for share issuance: NT$37,201,170 (150 shares issued free of charge per 1,000 shares) (2) Capitalization of capital reserve for share issuance: NT$18,600,580 (75 shares issued free of charge per 1,000 shares) 4. Ex-Rights (Ex-Dividend) Trading Day: 115/08/26 5. Last Transfer Date: 115/08/27 6. Start Date of Transfer Suspension: 115/08/28 7. End Date of Transfer Suspension: 115/09/01 8. Ex-Rights (Ex-Dividend) Benchmark Date: 115/09/01 9. Final Date for Bond Conversion Application: Not applicable 10. Start Date of Bond Conversion Suspension: Not applicable 11. End Date of Bond Conversion Suspension: Not applicable 12. Ordinary Share Cash Dividend Payment Date: 115/04/10 13. Whether Part or All of the Cash Dividend is Paid in Foreign Currency (please enter 'Yes' or 'No'): No 14. Currency for Foreign Cash Dividend: Not applicable 15. Recipients of Foreign Cash Dividend: Not applicable 16. Method for Determining Exchange Rate for Foreign Cash Dividend: Not applicable 17. Other Matters to be Disclosed: (1) The company's plan for capital increase using retained earnings and capital reserve for the year 114 has been approved and reported effective by the Financial Supervisory Commission on 115/07/03. (2) The new shares issued from retained earnings will be allocated based on shareholders' holdings as recorded in the shareholder register on the benchmark date. For every 1,000 shares held, 150 shares will be issued free of charge from retained earnings, and 75 shares from capital reserve. Fractional shares less than one share will be consolidated into whole shares by shareholders within five days from the benchmark date. Unconsolidated or unconsolidatable fractional shares will be paid in cash at par value (rounded to the nearest dollar), which may be used to offset CSDP transfer fees or non-physical registration fees. The Chairman is authorized to arrange for specific persons to purchase such fractional shares at par value. (3) The rights and obligations of the newly issued shares from this capital increase are identical to those of the originally issued shares. (4) If changes are required due to regulatory requirements or objective circumstances regarding the new share issuance from this capital increase, the Chairman is authorized to handle all matters accordingly.